Benchmark Reiterates Speculative Buy on Genelux, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bruce Jackson has reiterated a Speculative Buy rating on Genelux (NASDAQ:GNLX) and maintained a $25 price target.
June 03, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bruce Jackson has reiterated a Speculative Buy rating on Genelux and maintained a $25 price target.
The reiteration of a Speculative Buy rating and the maintenance of a $25 price target by a reputable analyst can positively influence investor sentiment and potentially drive short-term price appreciation for Genelux.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100